About 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide
2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide (PubChem CID 20600182) has the molecular formula C36H60ClN7O6S2
and a molecular weight of 786.51 g/mol. Its IUPAC name is 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide.
Analyze 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide?
The IUPAC name of 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide (CID 20600182) is 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide.
What is the SMILES notation for 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide?
The canonical SMILES for 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide is CCCCCCCCCCCCC(Oc1ccc(NS(=O)(=O)CCCC)cc1NS(C)(=O)=O)C(=O)NC(C)(C)C(C)(C)c1nnc2c(Cl)c(C)[nH]n12.
What is the InChIKey of 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide?
The InChIKey is CFYYVJKXGSHNNI-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H60ClN7O6S2/c1-9-11-13-14-15-16-17-18-19-20-21-30(33(45)38-36(6,7)35(4,5)34-40-39-32-31(37)26(3)41-44(32)34)50-29-23-22-27(25-28(29)43-51(8,46)47)42-52(48,49)24-12-10-2/h22-23,25,30,41-43H,9-21,24H2,1-8H3,(H,38,45).
What are the key properties of 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide?
2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide has a molecular weight of 786.51 g/mol, XLogP of 7.86, 24 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(butylsulfonylamino)-2-(methanesulfonamido)phenoxy]-N-[3-(7-chloro-6-methyl-5H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)-2,3-dimethylbutan-2-yl]tetradecanamide is sourced from PubChem (CID 20600182), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).